Compare Orchid Pharma with MANGALAM DRUGS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs MANGALAM DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA MANGALAM DRUGS ORCHID PHARMA/
MANGALAM DRUGS
 
P/E (TTM) x -17.0 11.2 - View Chart
P/BV x 2.5 1.5 166.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ORCHID PHARMA   MANGALAM DRUGS
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-21
MANGALAM DRUGS
Mar-21
ORCHID PHARMA/
MANGALAM DRUGS
5-Yr Chart
Click to enlarge
High Rs2,465175 1,406.2%   
Low Rs1832 56.5%   
Sales per share (Unadj.) Rs110.3221.1 49.9%  
Earnings per share (Unadj.) Rs-28.517.7 -161.6%  
Cash flow per share (Unadj.) Rs-1.923.5 -7.9%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs159.982.7 193.3%  
Shares outstanding (eoy) m40.8215.83 257.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x11.30.5 2,403.7%   
Avg P/E ratio x-43.55.9 -742.0%  
P/CF ratio (eoy) x-665.64.4 -15,081.8%  
Price / Book Value ratio x7.81.3 620.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m50,6771,639 3,091.2%   
No. of employees `000NANA-   
Total wages/salary Rs m671299 224.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,5013,500 128.6%  
Other income Rs m15247 322.5%   
Total revenues Rs m4,6533,547 131.2%   
Gross profit Rs m294533 55.1%  
Depreciation Rs m1,08992 1,187.1%   
Interest Rs m52293 559.8%   
Profit before tax Rs m-1,165395 -294.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0115 0.0%   
Profit after tax Rs m-1,165280 -416.6%  
Gross profit margin %6.515.2 42.8%  
Effective tax rate %029.2 0.0%   
Net profit margin %-25.98.0 -324.0%  
BALANCE SHEET DATA
Current assets Rs m5,4991,320 416.6%   
Current liabilities Rs m1,4211,076 132.0%   
Net working cap to sales %90.67.0 1,303.0%  
Current ratio x3.91.2 315.6%  
Inventory Days Days207 292.5%  
Debtors Days Days1,101559 196.9%  
Net fixed assets Rs m6,8741,309 525.2%   
Share capital Rs m408158 257.9%   
"Free" reserves Rs m6,1211,151 531.6%   
Net worth Rs m6,5291,310 498.5%   
Long term debt Rs m4,27569 6,217.2%   
Total assets Rs m12,3732,628 470.7%  
Interest coverage x-1.25.2 -23.5%   
Debt to equity ratio x0.70.1 1,247.1%  
Sales to assets ratio x0.41.3 27.3%   
Return on assets %-5.214.2 -36.6%  
Return on equity %-17.821.4 -83.6%  
Return on capital %-6.035.4 -16.8%  
Exports to sales %88.10-   
Imports to sales %37.343.0 86.6%   
Exports (fob) Rs m3,966NA-   
Imports (cif) Rs m1,6771,506 111.4%   
Fx inflow Rs m3,9661,421 279.1%   
Fx outflow Rs m1,7291,507 114.8%   
Net fx Rs m2,237-85 -2,618.6%   
CASH FLOW
From Operations Rs m236276 85.6%  
From Investments Rs m672-313 -214.8%  
From Financial Activity Rs m-1,65027 -6,115.2%  
Net Cashflow Rs m-742-10 7,155.1%  

Share Holding

Indian Promoters % 90.0 50.5 178.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.2 0.0 51,800.0%  
FIIs % 1.8 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 10.0 49.5 20.2%  
Shareholders   34,798 21,071 165.1%  
Pledged promoter(s) holding % 32.7 11.6 282.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   CORAL LAB.  BIOCON   VIVIMED LABS  GODAVARI DRU  BIOFIL CHEMICALS  



Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Related Views on News

Why Did Orchid Pharma Shares Plunge 10% Today? (Views On News)

Jun 25, 2021

Orchid Pharma shares plunge 10% as company fixes OFS price at 72% discount.

Orchid Pharma Shares Zoom 7,700% in Seven Months. More Gains Ahead? (Views On News)

Jun 3, 2021

Here's why Orchid Pharma shares have rallied 7,700% in seven months.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA SHARE PRICE


Dec 3, 2021 (Close)

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ORCHID PHARMA 5-YR ANALYSIS

COMPARE ORCHID PHARMA WITH

MARKET STATS